EP
DPLO

Elkfork Partners’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Elkfork Partners’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,612
Closed -$44K – 1068
2019
Q1 		$44K Hold
7,612
– – ﹤0.01% 989
2018
Q4 		$102K Buy
7,612
+1,232
+19% +$20.8K ﹤0.01% 890
2018
Q3 		$124K Buy
6,380
+2,178
+52% +$46.4K ﹤0.01% 931
2018
Q2 		$107K Buy
4,202
+44
+1% +$1.03K ﹤0.01% 912
2018
Q1 		$84K Buy
+4,158
New +$97K ﹤0.01% 959
2017
Q1 		– Sell
-1,100
Closed -$14K – 1017
2016
Q4 		$14K Buy
+1,100
New +$20.5K ﹤0.01% 975

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Elkfork Partners's DPLO Position: Q2 2019 in Review

Elkfork Partners sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 7,612 shares — an estimated $44K sold.

Elkfork Partners first reported a position in DPLO in Q4 2016 and held it in 6 quarters. The position peaked at $124K in Q3 2018. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Elkfork Partners reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Elkfork Partners sold 7,612 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $44K.
  • Elkfork Partners first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 6 quarters.
  • Elkfork Partners's DIPLOMAT PHARMACY, INC. position peaked at $124K in Q3 2018.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Elkfork Partners's 13F filing for Q2 2019, filed 13 Aug 2019.